Literature DB >> 1394309

Structures of the O chains from lipopolysaccharides of Campylobacter jejuni serotypes O:23 and O:36.

G O Aspinall1, A G McDonald, H Pang.   

Abstract

Lipopolysaccharides of C. jejuni serotypes O:23 and O:36 have been shown to contain structurally variable O polysaccharide chains with repeating units of four closely-related types: ----3)-beta-D-GlcpNAc-(1----3)-alpha-D-Galp-(1----2)-6d-alpha-D-alt-H epp-(1---- , ----3)-beta-D-GlcpNAc-(1----3)-alpha-D-Galp-(1----2)-6d-3-Me-alpha-D-alt -Hepp- (1----, ----3)-beta-D-GlcpNAc-(1----3)-alpha-D-Galp-(1----2)-D-glycero-alpha-D-a lt-Hepp - (1----, and ----3)-beta-D-GlcpNAc-(1----3)-alpha-D-Galp-(1----2)-3-Me-D-glycero-alph a-D-alt - Hepp-(1----. Structural methods included 1H- and 13C-NMR spectroscopy, methylation linkage analysis, fast atom bombardment mass spectrometry of methylated glycans, and selective fragmentations by the Smith degradation and N-deacetylation-nitrous acid deamination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394309     DOI: 10.1016/0008-6215(92)84003-b

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  18 in total

1.  Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.

Authors:  Neil J Oldfield; Anthony P Moran; Lorna A Millar; Martina M Prendergast; Julian M Ketley
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

2.  Detection and initial characterization of novel capsular polysaccharide among diverse Campylobacter jejuni strains using alcian blue dye.

Authors:  A V Karlyshev; B W Wren
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

3.  Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR.

Authors:  Frédéric Poly; Oralak Serichatalergs; Marc Schulman; Jennifer Ju; Cory N Cates; Margaret Kanipes; Carl Mason; Patricia Guerry
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Complete 6-deoxy-D-altro-heptose biosynthesis pathway from Campylobacter jejuni: more complex than anticipated.

Authors:  Matthew McCallum; Steven D Shaw; Gary S Shaw; Carole Creuzenet
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

5.  Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni.

Authors:  P Guerry; C P Ewing; T E Hickey; M M Prendergast; A P Moran
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Campylobacter jejuni biofilms up-regulated in the absence of the stringent response utilize a calcofluor white-reactive polysaccharide.

Authors:  Meghan K McLennan; Danielle D Ringoir; Emilisa Frirdich; Sarah L Svensson; Derek H Wells; Harold Jarrell; Christine M Szymanski; Erin C Gaynor
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

7.  Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.

Authors:  G O Aspinall; S Fujimoto; A G McDonald; H Pang; L A Kurjanczyk; J L Penner
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Demonstration of lipopolysaccharide with O-polysaccharide chains among different heat-stable serotypes of Campylobacter jejuni by silver staining of polyacrylamide gels.

Authors:  D C Blake; R G Russell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Comparison of predicted epimerases and reductases of the Campylobacter jejuni D-altro- and L-gluco-heptose synthesis pathways.

Authors:  Matthew McCallum; Gary S Shaw; Carole Creuzenet
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

10.  Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.

Authors:  Mario A Monteiro; Shahida Baqar; Eric R Hall; Yu-Han Chen; Chad K Porter; David E Bentzel; Lisa Applebee; Patricia Guerry
Journal:  Infect Immun       Date:  2008-12-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.